Varaico: Literature-Extracted Genetic Variants

Gene:CYP2C9
Variant:p.F114L
Back to variants list

CYP2C9

NM_000771.4:p.F114L

Associated Papers

Mining of molecular insights of CYP2A6 and its variants complex with coumarin (CYP2A6*-coumarin) using molecular dynamics simulation.

Yadav A et al.

Journal of Biomolecular Structure & Dynamics, 2023

Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.

McDonald MG et al.

The Journal of Pharmacology and Experimental Therapeutics, 2020

Distal effect of amino acid substitutions in CYP2C9 polymorphic variants causes differences in interatomic interactions against (S)-warfarin.

Lertkiatmongkol P et al.

Plos One, 2013

In vitro assessment of the allelic variants of cytochrome P450.

Hiratsuka M

Drug Metabolism and Pharmacokinetics, 2012

The blood-brain barrier thyroxine transporter organic anion-transporting polypeptide 1c1 displays atypical transport kinetics.

Westholm DE et al.

Endocrinology, 2009

CYP2C9 amino acid residues influencing phenytoin turnover and metabolite regio- and stereochemistry.

Mosher CM et al.

The Journal of Pharmacology and Experimental Therapeutics, 2009

Prediction of the effects of genetic polymorphism on the pharmacokinetics of CYP2C9 substrates from in vitro data.

Kusama M et al.

Pharmaceutical Research, 2009

Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9.

Mosher CM et al.

Biochemistry, 2008

Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivity.

Kerdpin O et al.

Biochemistry, 2004

Generation and evaluation of a CYP2C9 heteroactivation pharmacophore.

Egnell AC et al.

The Journal of Pharmacology and Experimental Therapeutics, 2003

Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profiles.

Tracy TS et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2002

Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding.

Haining RL et al.

Biochemistry, 1999

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."